Luye Pharma Group Ltd. (HKG:2186)
Hong Kong · Delayed Price · Currency is HKD 1.750
+0.050 (2.94%)
Sep 18, 2026, 4:08 PM HKT
Luye Pharma Group Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 8,216 | 4,492 | 4,937 | 3,239 | 2,324 | 2,438 |
Short-Term Investments | 500 | 1,000 | 62 | 1,272 | 1,247 | 387.86 |
Trading Asset Securities | 2,048 | 2,004 | 1,504 | 1,596 | 1,974 | 2,684 |
Cash & Short-Term Investments | 10,764 | 7,495 | 6,503 | 6,106 | 5,544 | 5,510 |
Cash Growth | 21.86% | 15.25% | 6.50% | 10.14% | 0.62% | 1.92% |
Accounts Receivable | 3,292 | 3,259 | 2,780 | 2,355 | 1,784 | 1,765 |
Other Receivables | - | 1,763 | 1,598 | 320.52 | 550.76 | 668.41 |
Receivables | 3,292 | 5,022 | 4,378 | 2,675 | 2,334 | 2,434 |
Inventory | 1,108 | 956.54 | 911.89 | 827.86 | 772.94 | 746.34 |
Prepaid Expenses | - | 346.17 | 323.6 | 94.13 | 466.54 | - |
Restricted Cash | - | 5.27 | - | - | 32 | 31.98 |
Other Current Assets | 3,134 | 1,408 | 1,192 | 999.44 | 1,636 | 1,675 |
Total Current Assets | 18,299 | 15,233 | 13,308 | 10,703 | 10,786 | 10,397 |
Property, Plant & Equipment | 5,188 | 5,303 | 5,339 | 5,089 | 4,589 | 4,203 |
Long-Term Investments | 3,122 | 3,596 | 2,492 | 1,968 | 1,114 | 582.2 |
Goodwill | 1,034 | 1,075 | 1,012 | 1,042 | 1,003 | 985.41 |
Other Intangible Assets | 6,675 | 5,467 | 5,464 | 4,805 | 4,448 | 4,080 |
Long-Term Deferred Tax Assets | 101.26 | 73.78 | 163.58 | 144.59 | 113.95 | 133.11 |
Long-Term Deferred Charges | - | 1,316 | 1,122 | 1,513 | 1,536 | 1,362 |
Other Long-Term Assets | 456.91 | 761.05 | 710.96 | 226.1 | 658.43 | 839.37 |
Total Assets | 34,875 | 32,825 | 29,612 | 25,491 | 24,250 | 22,582 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1,037 | 1,153 | 689.3 | 767.19 | 559.94 | 570.89 |
Accrued Expenses | - | 546.68 | 626.1 | 746.77 | 686.18 | 430.41 |
Short-Term Debt | 7,356 | 5,432 | 5,118 | 4,568 | 4,723 | 4,740 |
Current Portion of Long-Term Debt | 2,305 | 1,227 | 2,447 | 609.05 | 2,102 | 500.62 |
Current Portion of Leases | 37.8 | 35.32 | 19.79 | 18.5 | 15.25 | 22.75 |
Current Income Taxes Payable | 358.83 | 298.67 | 294.39 | 200.33 | 133.2 | 141.14 |
Current Unearned Revenue | 14.83 | 110.75 | 188.26 | 156.55 | 72.83 | 70.99 |
Other Current Liabilities | 1,476 | 1,132 | 1,386 | 1,071 | 1,195 | 853.54 |
Total Current Liabilities | 12,586 | 9,936 | 10,769 | 8,138 | 9,487 | 7,330 |
Long-Term Debt | 2,271 | 3,586 | 2,694 | 3,176 | 2,241 | 4,208 |
Long-Term Leases | 16.68 | 34.69 | 42.17 | 52.15 | 23.24 | 19.21 |
Long-Term Unearned Revenue | 308.74 | 280.22 | 130.56 | 172.22 | 384.44 | 209.39 |
Pension & Post-Retirement Benefits | 4.32 | 4.56 | 5.34 | 4.1 | 2.02 | 6.79 |
Long-Term Deferred Tax Liabilities | 32.48 | 0.49 | 36.48 | 47.26 | 56.03 | 57.87 |
Other Long-Term Liabilities | 2,078 | 624.47 | 181.03 | 372.65 | 1,013 | 1,636 |
Total Liabilities | 17,297 | 14,466 | 13,859 | 11,962 | 13,208 | 13,468 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 518.84 | 518.84 | 486.11 | 486.11 | 456.95 | 455.84 |
Additional Paid-In Capital | 5,064 | 5,064 | 4,250 | 4,159 | 3,077 | 1,716 |
Retained Earnings | - | 8,446 | 7,832 | 7,381 | 6,667 | 6,062 |
Treasury Stock | - | - | - | - | -279.56 | -279.56 |
Comprehensive Income & Other | 9,998 | 2,043 | 1,587 | 505.21 | 254.46 | 534.04 |
Total Common Equity | 15,581 | 16,073 | 14,155 | 12,531 | 10,176 | 8,488 |
Minority Interest | 1,997 | 2,287 | 1,599 | 997.31 | 865.77 | 625.78 |
Shareholders' Equity | 17,578 | 18,359 | 15,754 | 13,528 | 11,042 | 9,114 |
Total Liabilities & Equity | 34,875 | 32,825 | 29,612 | 25,491 | 24,250 | 22,582 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 11,987 | 10,315 | 10,321 | 8,424 | 9,105 | 9,491 |
Net Cash (Debt) | -1,223 | -2,820 | -3,818 | -2,318 | -3,560 | -3,980 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.30 | -0.72 | -1.01 | -0.62 | -1.02 | -1.16 |
Filing Date Shares Outstanding | 3,995 | 3,995 | 3,762 | 3,762 | 3,550 | 3,541 |
Total Common Shares Outstanding | 3,995 | 3,995 | 3,762 | 3,762 | 3,550 | 3,541 |
Working Capital | 5,713 | 5,297 | 2,539 | 2,565 | 1,299 | 3,066 |
Book Value Per Share | 3.90 | 4.02 | 3.76 | 3.33 | 2.87 | 2.40 |
Tangible Book Value | 7,873 | 9,530 | 7,678 | 6,684 | 4,724 | 3,423 |
Tangible Book Value Per Share | 1.97 | 2.39 | 2.04 | 1.78 | 1.33 | 0.97 |
Buildings | - | 2,770 | 2,613 | 2,013 | 1,707 | 1,602 |
Machinery | - | 4,442 | 4,119 | 3,636 | 3,408 | 3,031 |
Construction In Progress | - | 751.55 | 884.73 | 1,381 | 1,081 | 832.93 |
Leasehold Improvements | - | 61.69 | 59.49 | 54.98 | 43.93 | 40.26 |